文档介绍：Thyroid Cancer
Thyroid Cancer
prehensive Guide to Clinical Management
Second Edition
Edited by
Leonard Wartofsky, MD, MPH, MACP
Douglas Van Nostrand, MD, FACP, P
Washington Hospital Center, Washington, DC
Forewords by
E. Chester Ridgway, MD, MACP
University of Colorado Health Sciences Medical Center, Denver, CO
and
Ernest L. Mazzaferri, MD, MACP
University of Florida, Gainesville, FL
© 2006 Humana Press Inc.
999 Riverview Drive, Suite 208
Totowa, New Jersey 07512
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means,
electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher.
All authored papers, comments, opinions, conclusions, or mendations are those of the author(s), and do not necessarily reflect the
views of the publisher.
Due diligence has been taken by the publishers, editors, and authors of this book to assure the accuracy of the information published and
to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set
forth in this text are accurate and in accord with the standards accepted at the time of publication. Notwithstanding, as new research,
changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs,
the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for
additional warnings and contraindications. This is of utmost importance when the mended drug herein is a new or infrequently used
drug. It is the responsibility of the treating physician to determine dosages and treatment strategies for individual patients. Further it is the
responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device us